14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.65 14.61 %
R2 4.48 10.38 %
R1 4.38 7.76 %
Current price: 4.06
Support S1 4.03 -0.704 %
S2 3.93 -3.32 %
S3 3.75 -7.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.79 17.98 %
R2 4.54 11.82 %
R1 4.09 0.739 %
Current price 4.06
Support S1 4.04 -0.493%
S2 3.95 -2.71%
S3 3.87 -4.68%

FATE Predictions History

7 years ago
JS predicted that FATE for 2017-04-18 is going $4.53 (2.26%)

7 years ago
JWick199 predicted that FATE for 2017-04-18 is going $4.59 (2.00%)

Rank:

7 years ago
JuanC Villegas predicted that FATE for 2017-04-18 is going $4.61 (2.44%)

7 years ago
Itthiched.Kriengyuttapoom.5680 predicted that FATE for 2017-04-18 is going $2.42 (-46.22%)

Rank:

7 years ago
JS predicted that FATE for 2016-10-03 is going $3.12 (0.00%)

7 years ago
TW predicted that FATE for 2016-09-22 is going $3.26 (2.52%)

Rank:
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT